Evidence map›Paper›PMID 42722935›Full record

ReviewTransgenic research2026

Bridging the bench-to-field gap: a quantitative multi-omics and CRISPR/Cas9 framework for climate-resilient agriculture.

Büşranur Demir, Erkan Anıl Aydin, Aykut Sağlam

Abstract readReview
PubMed Publisher
In one paragraph

Review in Transgenic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Büşranur DemirFaculty of Science, Department of Molecular Biology and Genetics, Karadeniz Technical University, 61080, Ortahisar, Trabzon, Turkey.ORCID http://orcid.org/0009-0001-7714-6257
Erkan Anıl AydinFaculty of Science, Department of Molecular Biology and Genetics, Karadeniz Technical University, 61080, Ortahisar, Trabzon, Turkey.ORCID http://orcid.org/0009-0003-3117-3844
Aykut SağlamFaculty of Science, Department of Molecular Biology and Genetics, Karadeniz Technical University, 61080, Ortahisar, Trabzon, Turkey. saglama@ktu.edu.tr.ORCID https://orcid.org/0000-0003-4102-7990

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global climate change and shrinking freshwater supplies threaten agricultural sustainability. A major translational bottleneck exists: drought-tolerant genotypes developed in labs often fail in open-field conditions due to phenotypic mismatch. Traditional single-gene approaches and static lab tests overlook genotype-by-environment (G × E) interactions, hormonal tradeoffs (involving Abscisic Acid, Jasmonic Acid, Brassinosteroids, and Melatonin), and artificial effects of pots. This review presents an integrated quantitative selection framework to bridge lab and field results. In this review, we propose a conceptual three-stage Predictive Translational Workflow designed to bridge lab and field outcomes by integrating multi-omics envirotyping with advanced mixed models like (G × E)-BLUP and MegaLMM. These methods group complex transcriptomic and metabolomic data into functional networks, filtering out lab artifacts and pinpointing core regulatory nodes stable in real climates. Finally, we show how this pipeline enables precise CRISPR/Cas9 editing of native promoters, reducing agronomic yield penalties in normal conditions and offering a streamlined, non-GMO path to field-resilient crops.

Indexed as

AgricultureCRISPR-Cas SystemsCrops, AgriculturalPlants, Genetically ModifiedClimate ChangeDrought ResistanceGene EditingMultiomicsCRISPR/Cas9Drought toleranceG×E modelingMulti-omics integrationNative promoter editingPredictive translational workflow

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.